Fortis Healthcare Q2 profit falls 3% as lower exceptional gain offsets revenue growth

EBITDA increased 12% to ₹623.2 crore from ₹556.3 crore a year ago. However, EBITDA margin contracted to 22.8% from 23.9% in the year-ago quarter.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Fortis Healthcare (FORTIS).
- Category: Orders & Deals.
Why it matters
A routine update for Fortis Healthcare. Use the price and stock snapshot to gauge how the market is responding.














